COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors

[1]  O. Ogunwobi,et al.  Increased risk of COVID-19-related admissions in patients with active solid organ cancer in the West Midlands region of the UK: a retrospective cohort study , 2021, BMJ Open.

[2]  K. Stronks,et al.  Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis , 2021, BMJ Global Health.

[3]  O. Olopade,et al.  The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort , 2021, Cancer.

[4]  S. Gomez,et al.  Anti-Asian American Racism: A Wake-Up Call for Population-Based Cancer Research , 2021, Cancer Epidemiology, Biomarkers & Prevention.

[5]  M. de Andrade,et al.  Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies , 2021, JCO oncology practice.

[6]  D. Blanch-Hartigan,et al.  Structural Racism and the COVID-19 Experience in the United States. , 2021, Health security.

[7]  A. Tewari,et al.  Increased Hospitalization and Mortality from COVID-19 in Prostate Cancer Patients , 2021, Cancers.

[8]  B. Koczwara,et al.  Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services , 2021, Supportive Care in Cancer.

[9]  R. Haque,et al.  SARS-CoV-2 Testing, Positivity Rates, and Healthcare Outcomes in a Cohort of 22,481 Breast Cancer Survivors. , 2021, JCO clinical cancer informatics.

[10]  D. Rader,et al.  Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients , 2021, JNCI cancer spectrum.

[11]  J. Jones,et al.  Readdressing the Needs of Cancer Survivors During COVID-19: A Path Forward , 2020, Journal of the National Cancer Institute.

[12]  N. Berger,et al.  Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection. , 2020, JAMA oncology.

[13]  A. Pareek,et al.  Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis , 2020, Clinical Oncology.

[14]  C. Pinto,et al.  Cumulative COVID‐19 incidence, mortality and prognosis in cancer survivors: A population‐based study in Reggio Emilia, Northern Italy , 2020, International journal of cancer.

[15]  S. Nadalin,et al.  COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry , 2020, Annals of Hematology.

[16]  J. Al-Tawfiq,et al.  COVID-19 disparity among racial and ethnic minorities in the US: A cross sectional analysis , 2020, Travel Medicine and Infectious Disease.

[17]  A. Harris,et al.  Trends in the Use of Telehealth During the Emergence of the COVID-19 Pandemic — United States, January–March 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[18]  J. Stevermer,et al.  Disparities in the use of telehealth at the onset of the COVID-19 public health emergency , 2020, Journal of telemedicine and telecare.

[19]  M. Chasen,et al.  Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020 , 2020, Supportive Care in Cancer.

[20]  Jen-Chin Wang,et al.  COVID-19 in Cancer Patients From New York City: A Comparative Single Center Retrospective Analysis , 2020, Cancer control : journal of the Moffitt Cancer Center.

[21]  M. Glymour,et al.  Exploring U.S. Shifts in Anti-Asian Sentiment with the Emergence of COVID-19 , 2020, International journal of environmental research and public health.

[22]  P. Karaca-Mandic,et al.  Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States. , 2020, JAMA internal medicine.

[23]  Stephen D. Persell,et al.  Knowledge and Behaviors of Adults with Underlying Health Conditions During the Onset of the COVID-19 U.S. Outbreak: The Chicago COVID-19 Comorbidities Survey , 2020, Journal of Community Health.

[24]  Arjun K. Ghosh,et al.  Cardio‐Oncology in the Era of the COVID‐19 Pandemic and Beyond , 2020, Journal of the American Heart Association.

[25]  J. Warner,et al.  Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study , 2020, Cancer discovery.

[26]  R. Gale,et al.  Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission , 2020, Leukemia.

[27]  R. Kullar,et al.  Racial Disparity of Coronavirus Disease 2019 in African American Communities , 2020, The Journal of infectious diseases.

[28]  E. Robilotti,et al.  Determinants of COVID-19 disease severity in patients with cancer , 2020, Nature Medicine.

[29]  R. Carlos,et al.  The Coronavirus Disease 2019 (COVID-19) Pandemic: A Patient-Centered Model of Systemic Shock and Cancer Care Adherence , 2020, Journal of the American College of Radiology : JACR.

[30]  Alokkumar Jha,et al.  Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study , 2020, The Lancet.

[31]  S. Kalnicki,et al.  Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System , 2020, Cancer discovery.

[32]  M. Santillana,et al.  Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak , 2020, Cancer discovery.

[33]  Nan-shan Zhong,et al.  Cardiovascular comorbidity and its impact on patients with COVID-19 , 2020, European Respiratory Journal.

[34]  R. Gale,et al.  COVID-19 in persons with haematological cancers , 2020, Leukemia.

[35]  S. Peddada,et al.  Potential impact of the COVID‐19 pandemic on financial toxicity in cancer survivors , 2020, Head & neck.

[36]  H. Miyashita,et al.  Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City , 2020, Annals of Oncology.

[37]  Lynnette Brammer,et al.  Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[38]  O. Al-Quteimat,et al.  The Impact of the COVID-19 Pandemic on Cancer Patients , 2020, American journal of clinical oncology.

[39]  L. G. Conway,et al.  Social Psychological Measurements of COVID-19: Coronavirus Perceived Threat, Government Response, Impacts, and Experiences Questionnaires , 2020 .

[40]  R. Fisher,et al.  A War on Two Fronts: Cancer Care in the Time of COVID-19 , 2020, Annals of Internal Medicine.

[41]  C. Wang,et al.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China , 2020, Annals of Oncology.

[42]  M. Chua,et al.  SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China , 2020, JAMA oncology.

[43]  Wei Wang,et al.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.

[44]  Guillermo J. Lagos-Grisales,et al.  Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis , 2020, Travel Medicine and Infectious Disease.

[45]  Ruchong Chen,et al.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.

[46]  H. Cohen,et al.  Comorbidity in older adults with cancer. , 2016, Journal of geriatric oncology.

[47]  Gary L. Kreps,et al.  The Health Information National Trends Survey (HINTS): Development, Design, and Dissemination , 2004, Journal of health communication.

[48]  T. Tabuchi,et al.  Coronavirus Disease , 2021, Encyclopedia of the UN Sustainable Development Goals.